Significantly elevated PD-1 expression was observed on B cells from patients with CLL (40.20 ± 6.601) compared to the control group (6.690 ± 0.8160; p < 0.0001) (Figure 3A). This evidence concerns the gene PDCD1 and B-cell chronic lymphocytic leukemia.